TERM ID="NYU_TERM_1" STRING="Dabigatran etexilate" FREQUENCY=1 START=609 END=629 LEMMA="DABIGATRAN ETEXILATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_2" STRING="New oral anticoagulants" FREQUENCY=1 START=0 END=23 LEMMA="NEW ORAL ANTICOAGULANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="anticoagulant drugs" FREQUENCY=1 START=235 END=254 LEMMA="ANTICOAGULANT DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_4" STRING="anticoagulation" FREQUENCY=1 START=468 END=483 LEMMA="ANTICOAGULATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_5" STRING="apixaban" FREQUENCY=1 START=199 END=207 LEMMA="APIXABAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="atrial fibrillation" FREQUENCY=1 START=272 END=291 LEMMA="ATRIAL FIBRILLATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="clotting" FREQUENCY=1 START=690 END=698 LEMMA="CLOTTING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="coronary syndromes" FREQUENCY=1 START=301 END=319 LEMMA="CORONARY SYNDROME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="cost-effectiveness ratio" FREQUENCY=1 START=898 END=922 LEMMA="COST-EFFECTIVENESS RATIO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="dabigatran etexilate" FREQUENCY=1 START=140 END=160 LEMMA="DABIGATRAN ETEXILATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_11" STRING="factor X" FREQUENCY=1 START=176 END=184 LEMMA="FACTOR X" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="laboratory tests" FREQUENCY=1 START=669 END=685 LEMMA="LABORATORY TEST" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="laboratory tests for clotting" FREQUENCY=1 START=669 END=698 LEMMA="CLOTTING LABORATORY TEST" LEMMA_FREQUENCY=1 HEAD_TERM="laboratory tests" HEAD_LEMMA="LABORATORY TEST"
TERM ID="NYU_TERM_14" STRING="need information" FREQUENCY=1 START=531 END=547 LEMMA="NEED INFORMATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="oral inhibitors" FREQUENCY=1 START=106 END=121 LEMMA="ORAL INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="perspectives" FREQUENCY=1 START=58 END=70 LEMMA="PERSPECTIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="pharmacoeconomic studies" FREQUENCY=1 START=844 END=868 LEMMA="PHARMACOECONOMIC STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="recommendations" FREQUENCY=1 START=25 END=40 LEMMA="RECOMMENDATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="rivaroxaban" FREQUENCY=2 START=186 END=197 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="rivaroxaban" FREQUENCY=2 START=631 END=642 LEMMA="RIVAROXABAN" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_21" STRING="standard-of-care warfarin" FREQUENCY=1 START=381 END=406 LEMMA="STANDARD-OF-CARE WARFARIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="thrombin" FREQUENCY=1 START=130 END=138 LEMMA="THROMBIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="vascular medicine" FREQUENCY=1 START=487 END=504 LEMMA="VASCULAR MEDICINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="warfarin" FREQUENCY=1 START=926 END=934 LEMMA="WARFARIN" LEMMA_FREQUENCY=1
